{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/15370-170#drug","name":"RELAFEN DS","alternateName":"NABUMETONE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"15370-170"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA203166"},{"@type":"PropertyValue","propertyID":"UNII","value":"LW0TIW155Z"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"a9a0af85-6c43-4a2d-ba75-0be4ca64c931"}],"activeIngredient":"NABUMETONE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Carwin Pharmaceutical Associates, LLC"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA203166","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9a0af85-6c43-4a2d-ba75-0be4ca64c931","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=15370-170"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-14T20:41:34.436Z"}}